The 21st century has, in many ways, been shaped by the rapid advancements in technology and medicine. As we edge into the next decade, one of the most profound shifts on the horizon concerns the CPG and “Big Food” industries. Their challenge? Adapting to the changing consumer behaviors driven by the rising adoption of GLP-1 class pharmaceuticals.
Este informe está destinado exclusivamente a
Miembros ejecutivos, para facilitarle la afiliación, puede hacer clic a continuación y acceder a cientos de informes, a nuestra lista DTC Power List y a otras herramientas que le ayudarán a tomar decisiones de alto nivel.
Únete aquí
